Decades of Expertise

We harness decades of expertise in advanced micro and nanotechnology to tackle complex formulation challenges and drive innovative drug development solutions.Our comprehensive capabilities include high-energy media milling, micronization, spray drying, and lyophilization.

These technologies enable us to enhance bioavailability, improve stability, formulate higher doses, increase safety and patient compliance, control release rates, and protect unstable APIs from degradation. With a proven track record that includes scaling and commercializing nanoparticle technologies like zinc oxide (Z-Cote®) for skincare applications in the 1990s, we continue to lead in nanoparticulate projects, including those involving highly potent APIs and controlled substances.

Agno Pharma is uniquely equipped with aseptic and sterile capabilities for nanomilling, allowing us to perform commercial production under stringent cleanroom conditions. As pioneers in nanomilling, our Nanomilling Feasibility Program delivers rapid results, providing particle size distribution data, short-term stability assessments, and material for small animal pharmacokinetic studies within just 8 weeks. This process has proven effective for numerous BCS class II and IV APIs, contributing to the FDA approval of over 18 nanomilled drug products since 2000 across solid and liquid dosage forms. For organizations seeking to optimize poorly water-soluble APIs, Agno Pharma stands ready to transform formulation challenges into successful commercial realities through our expertise, facilities, and commitment to innovation.